Poxel SA
PAR:POXEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Poxel SA
PAR:POXEL
|
FR |
|
O
|
Olin Corp
F:OLN
|
US |
Intrinsic Value
The intrinsic value of Poxel SA (POXEL) under the Base Case is 1.068 EUR per share.
Compared with the current market price of 0.1736 EUR, the stock appears
Undervalued by 84% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Poxel Does
Poxel SA is a French biopharmaceutical company that focuses on drugs for metabolic diseases, especially type 2 diabetes and related liver disorders. It does not sell a broad range of medicines; instead, it develops a small number of drug candidates and works through partners to bring them to market. Its best-known program is imeglimin, a diabetes treatment that has been developed with commercial partners in Asia.
- Headquarters
- France FR
- Employees
- 5
- IPO date
- Feb 6, 2015
Earnings Waterfall
Poxel SA
The intrinsic value for Poxel SA (POXEL) under the Base Case is 1.068 EUR.
Compared with the current market price of 0.1736 EUR, the stock appears Undervalued by 84% .